The potent immunomodulatory effect of HLA-G molecules could mitigate the chronic inflammatory process, a key component in the pathogenesis of IPF, thereby contributing to a slower progression of the disease. This evidence concerns the gene HLA-G and idiopathic pulmonary fibrosis.